Literature DB >> 18974463

Correlation between hepatitis B genotypes, 1896 precore mutation, virus loads and liver dysfunction in an Indian population.

Perumal Vivekanandan1, Sara Bissett, Samreen Ijaz, Chong Gee Teo, Gopalan Sridharan, Sukanya Raghuraman, Hubert Darius Daniel, Manohar L Kavitha, Dolly Daniel, George M Chandy, Priya Abraham.   

Abstract

BACKGROUND/
OBJECTIVES: Hepatitis B virus (HBV) genotypes may differ in pathogenicity. However, the interplay between different virus characteristics such as genotypes, mutants and virus loads has not been well studied . We investigated the association between HBV genotype, presence of 1896 precore mutation and HBV viral loads in patients with HBV-related liver disease.
METHODS: One hundred and sixteen HBV DNA-seropositive patients attending a gastroenterology outpatient clinic and 107 HBV DNA-seropositive blood donors were recruited. The subjects were stratified as those with normal (Group I, n=164) and elevated (Group II, n=59) ALT levels. The HBV genotype and the presence of the 1896 precore mutation were determined, and plasma HBV DNA levels measured.
RESULTS: Genotype C was more common in Group II than in Group I (10 (17%) vs. 4 (2.4%); p< 0.005). There was no relationship between the 1896 precore mutation and the HBV DNA levels. Subjects with genotype C (n=14) had higher HBV DNA levels than those with genotypes A (n=33) or D (n=158).
CONCLUSIONS: The infecting genotype, but not the presence of 1896 precore mutation, correlates with HBV load. The association of genotype C with higher virus loads and with elevated ALT may point to a greater pathogenicity of this genotype.

Entities:  

Mesh:

Year:  2008        PMID: 18974463

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  1 in total

1.  Correlation between viral load of HBV in chronic hepatitis B patients and precore and Basal core promoter mutations.

Authors:  Soad Ghabeshi; Zohreh Sharifi; Seyed Masoud Hosseini; Mahmood Mahmoodian Shooshtari
Journal:  Hepat Mon       Date:  2013-02-18       Impact factor: 0.660

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.